YU312781A - Process for obtaining 4-amino-6,7-dimethoxy-2-piperazine quinazoline - Google Patents
Process for obtaining 4-amino-6,7-dimethoxy-2-piperazine quinazolineInfo
- Publication number
- YU312781A YU312781A YU03127/81A YU312781A YU312781A YU 312781 A YU312781 A YU 312781A YU 03127/81 A YU03127/81 A YU 03127/81A YU 312781 A YU312781 A YU 312781A YU 312781 A YU312781 A YU 312781A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- quinazoline
- dimethoxy
- piperazine
- amino
- obtaining
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/22—Nitrogen and oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/42—One nitrogen atom
- C07D251/44—One nitrogen atom with halogen atoms attached to the two other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/42—One nitrogen atom
- C07D251/46—One nitrogen atom with oxygen or sulfur atoms attached to the two other ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8041411 | 1980-12-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU312781A true YU312781A (en) | 1984-12-31 |
Family
ID=10518236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU03127/81A YU312781A (en) | 1980-12-29 | 1981-12-29 | Process for obtaining 4-amino-6,7-dimethoxy-2-piperazine quinazoline |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US4435401A (pl) |
| EP (1) | EP0055583B1 (pl) |
| JP (1) | JPS57181068A (pl) |
| KR (1) | KR830007635A (pl) |
| AR (1) | AR228631A1 (pl) |
| AT (1) | ATE15191T1 (pl) |
| AU (1) | AU529367B2 (pl) |
| CA (1) | CA1165318A (pl) |
| CS (1) | CS236667B2 (pl) |
| DD (1) | DD201901A5 (pl) |
| DE (1) | DE3172089D1 (pl) |
| DK (1) | DK152430C (pl) |
| ES (1) | ES8405787A1 (pl) |
| FI (1) | FI70411C (pl) |
| GR (1) | GR76980B (pl) |
| IE (1) | IE52232B1 (pl) |
| IL (1) | IL64665A (pl) |
| NO (1) | NO814454L (pl) |
| PH (1) | PH17079A (pl) |
| PL (2) | PL136268B1 (pl) |
| PT (1) | PT74205B (pl) |
| YU (1) | YU312781A (pl) |
| ZA (1) | ZA818932B (pl) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI70411C (fi) * | 1980-12-29 | 1986-09-19 | Pfizer | Foerfarande foer framstaellning av nya antihypertensiva 4-amino-6,7-dimetoxi-2-piperazinokinazolin derivat |
| DE3114088A1 (de) * | 1981-04-08 | 1982-10-28 | Bayer Ag, 5090 Leverkusen | Wasserloesliche triazinverbindungen, ihre herstellung und ihre verwendung |
| FR2521560A1 (fr) * | 1982-02-17 | 1983-08-19 | Adir | Nouveaux derives de piperazine et d'homopiperazine, leurs procedes de preparation et les compositions pharmaceutiques les renfermant |
| CH651027A5 (de) * | 1982-11-12 | 1985-08-30 | Sandoz Ag | Heterocyclische verbindungen, ihre herstellung und verwendung. |
| US5001125A (en) | 1984-03-26 | 1991-03-19 | Janssen Pharmaceutica N.V. | Anti-virally active pyridazinamines |
| JPS6267077A (ja) * | 1985-09-18 | 1987-03-26 | Mitsui Petrochem Ind Ltd | キナゾリン誘導体及び医薬 |
| US4734418A (en) * | 1984-12-14 | 1988-03-29 | Mitsui Petrochemical Industries, Ltd. | Quinazoline compounds and antihypertensives |
| JPS61140568A (ja) * | 1984-12-14 | 1986-06-27 | Mitsui Petrochem Ind Ltd | キナゾリン誘導体及びそれを有効成分とする血圧降下剤 |
| AT384218B (de) * | 1985-12-04 | 1987-10-12 | Gerot Pharmazeutika | Verfahren zur herstellung von neuen chinazolin-derivaten |
| US5072564A (en) * | 1988-10-11 | 1991-12-17 | Campana Technology, Inc. | Decorative panel |
| EP0489925B1 (en) * | 1990-07-03 | 1996-06-12 | Mitsui Petrochemical Industries, Ltd. | Pyrimidine compound and pharmaceutically acceptable salt thereof |
| IL108630A0 (en) * | 1993-02-18 | 1994-05-30 | Fmc Corp | Insecticidal substituted 2,4-diaminoquinazolines |
| IT1286302B1 (it) * | 1996-04-10 | 1998-07-08 | Rotta Research Lab | Chinazoline-4-amino-2-(piperidino-1-il-4-sostituite) ad attivita' anti-ipertensiva, procedimento per la loro preparazione e loro uso |
| SK285198B6 (sk) * | 1997-10-27 | 2006-08-03 | Neurosearch A/S | Homopiperazínový derivát, farmaceutická kompozícia obsahujúca tento derivát a jeho použitie |
| US6150362A (en) * | 1997-12-12 | 2000-11-21 | Henkin; Jack | Triazine angiogenesis inhibitors |
| US6825198B2 (en) * | 2001-06-21 | 2004-11-30 | Pfizer Inc | 5-HT receptor ligands and uses thereof |
| US20050119251A1 (en) * | 2001-12-21 | 2005-06-02 | Jian-Min Fu | Nicotinamide derivatives and their use as therapeutic agents |
| MY145822A (en) * | 2004-08-13 | 2012-04-30 | Neurogen Corp | Substituted biaryl piperazinyl-pyridine analogues |
| CA2580762A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as therapeutic agents |
| US20080167321A1 (en) * | 2004-09-20 | 2008-07-10 | Xenon Pharmaceuticals Inc. | Pyridine Derivatives For Inhibiting Human Stearoyl-Coa-Desaturase |
| CA2580845A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase |
| AU2005286648A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
| MX2007003325A (es) | 2004-09-20 | 2007-06-05 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como inhibidores estearoil-coa-desaturasa. |
| WO2006101521A2 (en) | 2004-09-20 | 2006-09-28 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| BRPI0515478A (pt) | 2004-09-20 | 2008-07-22 | Xenon Pharmaceuticals Inc | derivados heterocìclicos e seu uso como mediadores de estearoil-coa-desaturase |
| BRPI0515483A (pt) | 2004-09-20 | 2008-07-22 | Xenon Pharmaceuticals Inc | derivados heterocìclicos para o tratamento de doenças mediadas por enzimas estearoil-coa desaturase |
| AR051294A1 (es) * | 2004-09-20 | 2007-01-03 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa |
| CN101208089A (zh) | 2005-06-03 | 2008-06-25 | 泽农医药公司 | 氨基噻唑衍生物作为人硬酯酰-CoA去饱和酶抑制剂 |
| EA016564B1 (ru) | 2007-03-15 | 2012-05-30 | Новартис Аг | Бензил- и пиридинилпроизводные в качестве модуляторов пути передачи сигнала hedgehog |
| US20100041663A1 (en) | 2008-07-18 | 2010-02-18 | Novartis Ag | Organic Compounds as Smo Inhibitors |
| GB201008210D0 (en) * | 2010-05-17 | 2010-06-30 | Senexis Ltd | Compounds |
| GB201008209D0 (en) * | 2010-05-17 | 2010-06-30 | Senexis Ltd | Compounds |
| WO2024194756A1 (en) | 2023-03-17 | 2024-09-26 | Pfizer Inc. | Modulating the innate immunity of rna |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3496179A (en) * | 1967-10-11 | 1970-02-17 | Pfizer & Co C | 2-amino-3,4-dihydroquinazolines |
| US3517005A (en) | 1967-10-26 | 1970-06-23 | Pfizer & Co C | Certain 2- and 4-substituted quinazolines |
| US3511836A (en) | 1967-12-13 | 1970-05-12 | Pfizer & Co C | 2,4,6,7-tetra substituted quinazolines |
| US3669968A (en) | 1970-05-21 | 1972-06-13 | Pfizer | Trialkoxy quinazolines |
| US3900476A (en) | 1973-05-17 | 1975-08-19 | Upjohn Co | 2(2'-pyrimidylamino)quinazolines and their preparation |
| US3935213A (en) * | 1973-12-05 | 1976-01-27 | Pfizer Inc. | Process for hypotensive 4-amino-2-(piperazin-1-yl) quinazoline derivatives |
| US4062844A (en) * | 1976-09-20 | 1977-12-13 | Pfizer Inc. | Process for preparing hypotensive 2-(4-aroylpiperazin-1-yl)-amino-6,7-dimethoxyquinazolines |
| US4101548A (en) * | 1977-02-22 | 1978-07-18 | Bristol-Myers Company | 1,2,3-Thiadiazole amides |
| US4171363A (en) | 1977-02-22 | 1979-10-16 | Bristol-Myers Company | 1,2,3-Thiadiazole process |
| US4188390A (en) | 1977-11-05 | 1980-02-12 | Pfizer Inc. | Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines |
| US4161595A (en) | 1978-10-02 | 1979-07-17 | Bristol-Myers Company | Levulinic acid salt |
| FI67699C (fi) * | 1979-01-31 | 1985-05-10 | Orion Yhtymae Oy | Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan |
| US4287341A (en) | 1979-11-01 | 1981-09-01 | Pfizer Inc. | Alkoxy-substituted-6-chloro-quinazoline-2,4-diones |
| US4351832A (en) | 1980-04-18 | 1982-09-28 | American Home Products Corporation | 2-(Piperazinyl)-4-pyrimidinamines |
| FI70411C (fi) * | 1980-12-29 | 1986-09-19 | Pfizer | Foerfarande foer framstaellning av nya antihypertensiva 4-amino-6,7-dimetoxi-2-piperazinokinazolin derivat |
-
1981
- 1981-12-17 FI FI814055A patent/FI70411C/fi not_active IP Right Cessation
- 1981-12-22 EP EP81306025A patent/EP0055583B1/en not_active Expired
- 1981-12-22 AT AT81306025T patent/ATE15191T1/de active
- 1981-12-22 DK DK569781A patent/DK152430C/da not_active IP Right Cessation
- 1981-12-22 DE DE8181306025T patent/DE3172089D1/de not_active Expired
- 1981-12-23 ZA ZA@@@@00818932A patent/ZA818932B/xx unknown
- 1981-12-23 CA CA000393109A patent/CA1165318A/en not_active Expired
- 1981-12-23 IE IE3053/81A patent/IE52232B1/en unknown
- 1981-12-23 US US06/333,672 patent/US4435401A/en not_active Expired - Lifetime
- 1981-12-23 AU AU78846/81A patent/AU529367B2/en not_active Ceased
- 1981-12-28 PH PH26680A patent/PH17079A/en unknown
- 1981-12-28 DD DD81236333A patent/DD201901A5/de unknown
- 1981-12-28 GR GR66910A patent/GR76980B/el unknown
- 1981-12-28 NO NO814454A patent/NO814454L/no unknown
- 1981-12-28 KR KR1019810005269A patent/KR830007635A/ko unknown
- 1981-12-28 ES ES508383A patent/ES8405787A1/es not_active Expired
- 1981-12-28 AR AR287957A patent/AR228631A1/es active
- 1981-12-28 IL IL64665A patent/IL64665A/xx unknown
- 1981-12-28 JP JP56216057A patent/JPS57181068A/ja active Granted
- 1981-12-28 PT PT74205A patent/PT74205B/pt unknown
- 1981-12-29 CS CS819946A patent/CS236667B2/cs unknown
- 1981-12-29 YU YU03127/81A patent/YU312781A/xx unknown
- 1981-12-30 PL PL1981234523A patent/PL136268B1/pl unknown
- 1981-12-30 PL PL1981243280A patent/PL136217B1/pl unknown
-
1983
- 1983-08-24 US US06/525,964 patent/US4483857A/en not_active Expired - Lifetime
- 1983-08-24 US US06/526,005 patent/US4483859A/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU312781A (en) | Process for obtaining 4-amino-6,7-dimethoxy-2-piperazine quinazoline | |
| PT77082B (en) | Process for preparing 2-substituted 4-amino-6,7-dimethoxyquinolines | |
| YU165382A (en) | Process for producing 2-piperazinyl-6,7-dimethoxy-quinazoline | |
| YU25682A (en) | Process for obtaining anittumoral quinazoline derivatives | |
| YU198283A (en) | Process for obtaining new substituted pyrimidines | |
| YU212784A (en) | Process for producing substituted aminocyclo-butene-3,4-diones | |
| GB2068961B (en) | Quinazoline derivatives | |
| YU42698B (en) | Process for obtaining penicillanoyl-oxymethyl-penicillanate-1,1,1',1'-tetraoxide | |
| YU255378A (en) | Process for obtaining antihypertensive quinazolines | |
| YU39155B (en) | Process for obtaining 2-(4-aroylpiperazine-1-yl)-4-amino-6,7-dimethoxy quinazolines | |
| IL62842A0 (en) | Process for the preparation of n-di-n-propyl-2,6-dinitro-4-trifluoro-methylaniline | |
| YU34181A (en) | Process for obtaining substituted 2-piperidino-4-amino-6,7-dimethoxy-quinazolines | |
| YU284181A (en) | Process for obtaining 2,3-dihydro-pyrane | |
| YU22980A (en) | Process for obtaining quinazolines | |
| DE3170650D1 (en) | 2-alkyl-5-alkylsulfonyl-4,6-dihalogen pyrimidines and process for their preparation | |
| YU65979A (en) | Process for obtaining quinazoline | |
| IT1169216B (it) | Processo per preparare 5-ciano(3,4'-bipiridin)-6(1h)-one | |
| YU176683A (en) | Process for obtaining 4-nitro-1,2-hydrocarbyl-pyrazolidine | |
| YU233278A (en) | Process for obtaining quinazoline | |
| KE3866A (en) | 2-substituted 4-amino-6,7-dimethoxyquinolines | |
| YU263878A (en) | Process for obtaining antihypertensive quinazolines | |
| PT71139A (en) | Process for preparing quinazoline antihypertensives | |
| BG30841A1 (en) | N,n1- malonyl- bis- /n4- alkylpiperazimil- amid and method for its obtaining | |
| IE802105L (en) | Quinazoline derivatives | |
| IE801271L (en) | Quinazoline derivatives |